Dynavax Technologies Corporation (NASDAQ:DVAX) Archives

Dynavax Technologies Corporation (NASDAQ:DVAX) Reports Record HEPLISAV-B® Vaccine Net Revenue Of...

Matt Wade - November 13, 2020 0

Dynavax Technologies’(NASDAQ:DVAX) Appoints Peter Paradiso To Board And Its CFO To...

Gavins Felicity - October 1, 2020 0

The Bill & Melinda Gates Foundation Grants Dynavax Technologies Corporation (NASDAQ:DVAX)...

Kate Hudson - August 19, 2020 0

TriSalus Life Sciences Enters into an Asset Purchase Agreement under Which...

Gavins Felicity - August 13, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX)’s Collaboration with Mount Sinai to Develop a...

Kate Hudson - July 23, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Partners with Medicago to Investigate and Evaluate...

Matt Wade - July 16, 2020 0

Clover Biopharmaceuticals Commences Study On COVID-19 Vaccine Using Dynavax Technologies’ (NASDAQ:DVAX)...

Matt Wade - June 29, 2020 0

Dynavax Technologies Corporation (NASDAQ:DVAX) Completes Enrolment IN Study Evaluating Hepatitis B...

Gavins Felicity - June 23, 2020 0

Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...

Kate Hudson - August 5, 2022 0

Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...

IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...

August 4, 2022

Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...

August 3, 2022

Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study...

August 2, 2022

Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A....

August 1, 2022

Tag: Dynavax Technologies Corporation (NASDAQ:DVAX)

Recent Post